| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.001 | 0.98 | Opioid antagonist | 0.846 0.002 DBMET01858 0.887 0.001 DBMET01859 0.912 0.001 DBMET01860 0.798 0.002 DBMET01861 0.839 0.002 DBMET01862 | ||
| 0.981 | 0.003 | 0.981 | Analgesic | 0.924 0.004 DBMET01858 0.939 0.004 DBMET01859 0.978 0.004 DBMET01860 0.882 0.005 DBMET01861 0.928 0.004 DBMET01862 | ||
| 0.972 | 0.001 | 0.972 | Opioid mu receptor antagonist | 0.809 0.002 DBMET01858 0.857 0.001 DBMET01859 0.877 0.001 DBMET01860 0.741 0.002 DBMET01861 0.802 0.002 DBMET01862 | ||
| 0.95 | 0.001 | 0.95 | Opioid delta receptor antagonist | 0.778 0.002 DBMET01858 0.806 0.001 DBMET01859 0.867 0.001 DBMET01860 0.739 0.002 DBMET01861 0.764 0.002 DBMET01862 | ||
| 0.948 | 0.001 | 0.948 | Opioid kappa receptor antagonist | 0.758 0.001 DBMET01858 0.788 0.001 DBMET01859 0.826 0.001 DBMET01860 0.699 0.002 DBMET01861 0.737 0.002 DBMET01862 | ||
| 0.947 | 0.002 | 0.947 | Analgesic, opioid | 0.794 0.002 DBMET01858 0.859 0.002 DBMET01859 0.938 0.002 DBMET01860 0.76 0.003 DBMET01861 0.832 0.002 DBMET01862 | ||
| 0.934 | 0.001 | 0.934 | Opioid agonist | 0.781 0.002 DBMET01858 0.823 0.002 DBMET01859 0.917 0.001 DBMET01860 0.752 0.002 DBMET01861 0.794 0.002 DBMET01862 | ||
| 0.896 | 0.002 | 0.896 | Antipruritic | 0.749 0.003 DBMET01858 0.718 0.003 DBMET01859 0.715 0.003 DBMET01860 0.142 0.104 DBMET01861 0.398 0.006 DBMET01862 | ||
| 0.878 | 0.001 | 0.878 | Opioid mu receptor agonist | 0.695 0.002 DBMET01858 0.738 0.002 DBMET01859 0.798 0.001 DBMET01860 0.632 0.003 DBMET01861 0.678 0.002 DBMET01862 | ||
| 0.865 | 0.001 | 0.892 | Opioid delta receptor agonist | 0.664 0.002 DBMET01858 0.692 0.002 DBMET01859 0.892 0.001 DBMET01860 0.661 0.002 DBMET01861 0.706 0.002 DBMET01862 | DBMET01860 | |
| 0.797 | 0.001 | 0.797 | Opioid kappa receptor agonist | 0.593 0.001 DBMET01858 0.65 0.001 DBMET01859 0.644 0.001 DBMET01860 0.424 0.002 DBMET01861 0.479 0.002 DBMET01862 | ||
| 0.74 | 0.003 | 0.74 | Sigma receptor antagonist | 0.257 0.007 DBMET01858 0.398 0.005 DBMET01859 0.45 0.004 DBMET01860 0.052 0.033 DBMET01861 0.081 0.02 DBMET01862 | ||
| 0.496 | 0.002 | 0.496 | Toll-Like receptor 4 antagonist | 0.446 0.002 DBMET01858 0.42 0.002 DBMET01859 0.45 0.002 DBMET01860 0.398 0.003 DBMET01861 0.3 0.003 DBMET01862 | ||
| 0.505 | 0.031 | 0.632 | Immunosuppressant | 0.552 0.02 DBMET01858 0.45 0.047 DBMET01859 0.631 0.009 DBMET01860 0.632 0.009 DBMET01861 0.575 0.016 DBMET01862 | DBMET01861 | |
| 0.462 | 0.004 | 0.462 | Toll-Like receptor antagonist | 0.154 0.053 DBMET01858 0.298 0.007 DBMET01860 | ||
| 0.451 | 0.053 | 0.775 | Transcription factor NF kappa B inhibitor | 0.775 0.015 DBMET01858 0.27 0.114 DBMET01859 0.557 0.037 DBMET01860 0.433 0.056 DBMET01861 0.36 0.074 DBMET01862 | DBMET01858 | |
| 0.391 | 0.006 | 0.391 | Acetylcholine M1 receptor antagonist | 0.122 0.105 DBMET01858 0.158 0.067 DBMET01859 0.222 0.033 DBMET01860 | ||
| 0.405 | 0.039 | 0.463 | Spasmolytic | 0.463 0.029 DBMET01858 0.264 0.085 DBMET01859 0.328 0.06 DBMET01860 0.198 0.122 DBMET01862 | DBMET01858 | |
| 0.45 | 0.11 | 0.873 | Antiinflammatory | 0.73 0.025 DBMET01858 0.431 0.121 DBMET01859 0.466 0.103 DBMET01860 0.873 0.007 DBMET01861 0.442 0.114 DBMET01862 | DBMET01861 | |
| 0.325 | 0.003 | 0.325 | Nociceptin (N/OFQ) receptor antagonist | 0.09 0.007 DBMET01858 0.154 0.005 DBMET01859 0.149 0.005 DBMET01860 0.042 0.019 DBMET01862 | ||
| 0.306 | 0.016 | 0.479 | Protein kinase stimulant | 0.479 0.005 DBMET01858 0.243 0.028 DBMET01860 0.172 0.054 DBMET01861 | DBMET01858 | |
| 0.326 | 0.036 | 0.457 | Nitric oxide antagonist | 0.457 0.019 DBMET01858 0.241 0.054 DBMET01859 0.329 0.035 DBMET01860 0.437 0.021 DBMET01861 0.238 0.055 DBMET01862 | DBMET01858 | |
| 0.314 | 0.036 | 0.314 | Sigma receptor agonist | 0.182 0.068 DBMET01860 | ||
| 0.266 | 0.008 | 0.649 | Cyclooxygenase 3 inhibitor | 0.649 0.002 DBMET01858 0.122 0.075 DBMET01859 0.171 0.033 DBMET01860 0.141 0.056 DBMET01861 | DBMET01858 | |
| 0.257 | 0.047 | 0.257 | Anesthetic general | 0.177 0.089 DBMET01858 0.252 0.049 DBMET01860 | ||
| 0.23 | 0.05 | 0.389 | Hepatoprotectant | 0.389 0.014 DBMET01858 0.24 0.046 DBMET01859 0.219 0.055 DBMET01860 0.278 0.036 DBMET01861 0.231 0.05 DBMET01862 | DBMET01858 | |
| 0.21 | 0.031 | 0.21 | Toll-Like receptor 9 antagonist | 0.173 0.049 DBMET01860 | ||
| 0.19 | 0.016 | 0.222 | Antineoplastic alkaloid | 0.103 0.045 DBMET01858 0.092 0.053 DBMET01859 0.222 0.009 DBMET01860 0.131 0.034 DBMET01861 0.145 0.029 DBMET01862 | DBMET01860 | |
| 0.203 | 0.031 | 0.203 | Cholinergic antagonist | 0.132 0.064 DBMET01860 | ||
| 0.195 | 0.026 | 0.195 | Acetylcholine muscarinic antagonist | |||
| 0.172 | 0.003 | 0.172 | CC chemokine 5 receptor agonist | 0.136 0.005 DBMET01859 0.103 0.019 DBMET01860 0.082 0.057 DBMET01862 | ||
| 0.197 | 0.032 | 0.197 | Acetylcholine antagonist | 0.128 0.064 DBMET01860 | ||
| 0.193 | 0.069 | 0.193 | P-glycoprotein inhibitor | 0.182 0.078 DBMET01858 0.183 0.077 DBMET01860 | ||
| 0.127 | 0.003 | 0.127 | Nociceptin (N/OFQ) receptor agonist | 0.036 0.008 DBMET01858 0.054 0.005 DBMET01859 0.09 0.004 DBMET01860 0.022 0.014 DBMET01862 | ||
| 0.219 | 0.102 | 0.511 | Antioxidant | 0.511 0.019 DBMET01858 0.247 0.085 DBMET01859 0.248 0.084 DBMET01860 0.386 0.037 DBMET01861 0.274 0.072 DBMET01862 | DBMET01858 | |
| 0.143 | 0.026 | 0.541 | Breast cancer-resistant protein inhibitor | 0.438 0.005 DBMET01859 0.176 0.017 DBMET01860 0.541 0.004 DBMET01862 | DBMET01862 | |
| 0.232 | 0.129 | 0.253 | Caspase 3 stimulant | 0.234 0.127 DBMET01858 0.253 0.109 DBMET01860 0.199 0.17 DBMET01861 | DBMET01860 | |
| 0.166 | 0.065 | 0.248 | Cholinergic | 0.248 0.029 DBMET01860 | DBMET01860 | |
| 0.144 | 0.059 | 0.189 | Acetylcholinesterase inhibitor | 0.189 0.036 DBMET01860 | DBMET01860 | |
| 0.12 | 0.038 | 0.12 | Prolactin inhibitor | 0.101 0.054 DBMET01860 | ||
| 0.237 | 0.163 | 0.257 | Calcium channel activator | 0.257 0.139 DBMET01860 | DBMET01860 | |
| 0.112 | 0.04 | 0.112 | Alpha 2 adrenoreceptor antagonist | 0.091 0.055 DBMET01860 | ||
| 0.077 | 0.013 | 0.077 | Prolactin release inhibitor | 0.06 0.053 DBMET01858 0.064 0.038 DBMET01859 0.076 0.015 DBMET01860 0.061 0.046 DBMET01862 | ||
| 0.16 | 0.108 | 0.339 | Psychostimulant | 0.203 0.078 DBMET01858 0.339 0.034 DBMET01860 | DBMET01860 | |
| 0.146 | 0.096 | 0.191 | Interleukin 6 antagonist | 0.191 0.046 DBMET01858 0.147 0.094 DBMET01860 0.149 0.09 DBMET01861 | DBMET01858 | |
| 0.206 | 0.157 | 0.441 | Immunomodulator | 0.441 0.033 DBMET01858 | DBMET01858 | |
| 0.104 | 0.057 | 0.104 | Estrogen receptor beta antagonist | 0.103 0.058 DBMET01860 | ||
| 0.139 | 0.098 | 0.176 | Melanin inhibitor | 0.176 0.054 DBMET01858 0.164 0.065 DBMET01860 0.148 0.084 DBMET01861 | DBMET01858 | |
| 0.111 | 0.073 | 0.115 | Estrogen antagonist | 0.115 0.064 DBMET01860 | DBMET01860 | |
| 0.081 | 0.049 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 DBMET01858 0.091 0.04 DBMET01859 0.101 0.031 DBMET01860 0.102 0.029 DBMET01861 0.107 0.025 DBMET01862 | DBMET01862 | |
| 0.07 | 0.04 | 0.07 | Dopamine D1 antagonist | |||
| 0.047 | 0.026 | 0.049 | Parathyroid hormone antagonist | 0.049 0.024 DBMET01860 | DBMET01860 | |
| 0.022 | 0.006 | 0.022 | NMDA receptor phencyclidine site antagonist | 0.019 0.007 DBMET01860 | ||
| 0.024 | 0.011 | 0.024 | Vitamin D receptor antagonist | 0.024 0.012 DBMET01858 0.023 0.014 DBMET01860 | ||
| 0.049 | 0.037 | 0.049 | CC chemokine 5 receptor antagonist | |||
| 0.091 | 0.08 | 0.294 | Expectorant | 0.294 0.009 DBMET01858 0.097 0.072 DBMET01860 | DBMET01858 | |
| 0.031 | 0.023 | 0.062 | Estrogen receptor beta agonist | 0.057 0.018 DBMET01859 0.034 0.023 DBMET01860 0.062 0.017 DBMET01862 | DBMET01862 | |
| 0.099 | 0.092 | 0.129 | Microtubule formation inhibitor | 0.129 0.052 DBMET01858 0.118 0.063 DBMET01860 | DBMET01858 | |
| 0.235 | 0.231 | 0.443 | Apoptosis agonist | 0.443 0.094 DBMET01858 0.314 0.163 DBMET01860 0.438 0.096 DBMET01861 | DBMET01858 | |
| 0.017 | 0.018 | 0.02 | Progesterone receptor B antagonist | 0.02 0.013 DBMET01860 | DBMET01860 | |
| 0.162 | 0.164 | 0.244 | 5 Hydroxytryptamine release stimulant | 0.244 0.092 DBMET01860 | DBMET01860 | |
| 0.066 | 0.068 | 0.165 | Antineoplastic antibiotic | 0.164 0.028 DBMET01858 0.085 0.054 DBMET01860 0.165 0.028 DBMET01861 0.08 0.057 DBMET01862 | DBMET01861 | |
| 0.04 | 0.043 | 0.097 | Estrogen agonist | 0.093 0.019 DBMET01859 0.097 0.018 DBMET01862 | DBMET01862 | |
| 0.063 | 0.067 | 0.087 | Alpha 2a adrenoreceptor antagonist | 0.087 0.043 DBMET01860 | DBMET01860 | |
| 0.018 | 0.029 | 0.035 | Dopamine D1 agonist | 0.023 0.016 DBMET01859 0.029 0.009 DBMET01860 0.035 0.007 DBMET01862 | DBMET01862 | |
| 0.116 | 0.128 | 0.142 | Growth hormone agonist | 0.142 0.094 DBMET01860 | DBMET01860 | |
| 0.034 | 0.056 | 0.048 | Microtubule stabilization | 0.048 0.03 DBMET01858 | DBMET01858 | |
| 0.025 | 0.058 | 0.053 | Dopamine D2 agonist | 0.052 0.025 DBMET01859 0.053 0.025 DBMET01862 | DBMET01862 | |
| 0.072 | 0.117 | 0.107 | Anabolic | 0.098 0.065 DBMET01859 0.107 0.054 DBMET01862 | DBMET01862 | |
| 0.054 | 0.103 | 0.076 | Acetylcholine nicotinic antagonist | 0.076 0.06 DBMET01860 | DBMET01860 | |
| 0.036 | 0.086 | 0.202 | NMDA 2B receptor antagonist | 0.202 0.005 DBMET01859 0.149 0.009 DBMET01862 | DBMET01859 | |
| 0.17 | 0.224 | 0.259 | 5 Hydroxytryptamine uptake stimulant | 0.259 0.072 DBMET01860 | DBMET01860 | |
| 0.169 | 0.231 | 0.323 | Apoptosis antagonist | 0.323 0.071 DBMET01858 | DBMET01858 | |
| 0.122 | 0.189 | 0.401 | Free radical scavenger | 0.401 0.029 DBMET01858 0.182 0.113 DBMET01860 0.257 0.065 DBMET01861 | DBMET01858 | |
| 0.012 | 0.083 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET01858 0.022 0.019 DBMET01861 | DBMET01858 | |
| 0.025 | 0.106 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 DBMET01858 0.059 0.032 DBMET01861 | DBMET01858 | |
| 0.105 | 0.188 | 0.146 | Antimitotic | 0.146 0.125 DBMET01860 | DBMET01860 | |
| 0.043 | 0.127 | 0.057 | Lipocortins synthesis agonist | 0.057 0.042 DBMET01858 | DBMET01858 | |
| 0.14 | 0.228 | 0.207 | RNA-directed DNA polymerase inhibitor | 0.207 0.089 DBMET01859 0.206 0.091 DBMET01862 | DBMET01859 | |
| 0.101 | 0.194 | 0.168 | Interferon gamma antagonist | 0.168 0.058 DBMET01858 | DBMET01858 | |
| 0.198 | 0.323 | 0.273 | Caspase 9 stimulant | 0.273 0.225 DBMET01860 | DBMET01860 | |
| 0.055 | 0.186 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.035 DBMET01858 0.078 0.076 DBMET01861 | DBMET01858 | |
| 0.07 | 0.208 | 0.459 | Angiogenesis stimulant | 0.459 0.014 DBMET01858 0.32 0.042 DBMET01859 0.319 0.042 DBMET01861 0.35 0.032 DBMET01862 | DBMET01858 | |
| 0.014 | 0.156 | 0.049 | Dopamine D5 agonist | 0.049 0.019 DBMET01860 | DBMET01860 | |
| 0.107 | 0.263 | 0.481 | Hypoglycemic | 0.481 0.017 DBMET01858 0.214 0.1 DBMET01861 | DBMET01858 | |
| 0.083 | 0.242 | 0.135 | Adenylate cyclase stimulant | 0.135 0.091 DBMET01860 0.132 0.098 DBMET01862 | DBMET01860 | |
| 0.133 | 0.313 | 0.204 | Tyrosine 3 hydroxylase inhibitor | 0.204 0.128 DBMET01860 | DBMET01860 | |
| 0.032 | 0.223 | 0.088 | Glycine receptor antagonist | 0.088 0.045 DBMET01862 | DBMET01862 | |
| 0.017 | 0.215 | 0.053 | Antibiotic Aminoglycoside-like | 0.053 0.012 DBMET01858 0.045 0.016 DBMET01861 | DBMET01858 | |
| 0.068 | 0.295 | 0.329 | Immunostimulant | 0.329 0.07 DBMET01858 0.189 0.127 DBMET01862 | DBMET01858 | |
| 0.075 | 0.315 | 0.193 | Vasodilator | 0.193 0.11 DBMET01858 | DBMET01858 | |
| 0.062 | 0.306 | 0.206 | Interleukin agonist | 0.206 0.115 DBMET01858 | DBMET01858 | |
| 0.099 | 0.348 | 0.43 | Antithrombotic | 0.43 0.042 DBMET01858 0.21 0.165 DBMET01859 0.207 0.168 DBMET01862 | DBMET01858 | |
| 0.014 | 0.263 | 0.076 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.052 DBMET01859 0.076 0.035 DBMET01862 | DBMET01862 | |
| 0.039 | 0.298 | 0.126 | Lipid peroxidase inhibitor | 0.126 0.087 DBMET01858 | DBMET01858 | |
| 0.011 | 0.278 | 0.074 | HIV-1 integrase (Strand Transfer) inhibitor | 0.052 0.048 DBMET01859 0.074 0.034 DBMET01862 | DBMET01862 | |
| 0.061 | 0.344 | 0.294 | NOS3 expression enhancer | 0.294 0.019 DBMET01858 0.213 0.036 DBMET01861 | DBMET01858 | |
| 0.019 | 0.307 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 DBMET01858 | DBMET01858 | |
| 0.06 | 0.355 | 0.262 | Insulin secretagoues | 0.262 0.017 DBMET01858 | DBMET01858 | |
| 0.005 | 0.314 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET01859 0.031 0.014 DBMET01862 | DBMET01862 | |
| 0.049 | 0.379 | 0.238 | Platelet adhesion inhibitor | 0.238 0.053 DBMET01858 0.156 0.099 DBMET01859 0.177 0.084 DBMET01862 | DBMET01858 | |
| 0.039 | 0.372 | 0.093 | ABCA1 expression enhancer | 0.093 0.061 DBMET01861 | DBMET01861 | |
| 0.058 | 0.4 | 0.298 | DNA damaging | 0.298 0.058 DBMET01861 | DBMET01861 | |
| 0.098 | 0.443 | 0.304 | Peptidyltransferase inhibitor | 0.304 0.023 DBMET01858 0.225 0.071 DBMET01861 | DBMET01858 | |
| 0.037 | 0.394 | 0.127 | Cell wall synthesis inhibitor | 0.127 0.09 DBMET01858 | DBMET01858 | |
| 0.018 | 0.396 | 0.091 | Topoisomerase I inhibitor | 0.091 0.078 DBMET01858 | DBMET01858 | |
| 0.055 | 0.446 | 0.176 | DNA synthesis inhibitor | 0.176 0.16 DBMET01860 | DBMET01860 | |
| 0.01 | 0.467 | 0.069 | CDC25A inhibitor | 0.069 0.058 DBMET01862 | DBMET01862 | |
| 0.082 | 0.578 | 0.294 | Interleukin 2 agonist | 0.294 0.078 DBMET01858 0.205 0.18 DBMET01861 | DBMET01858 | |
| 0.013 | 0.552 | 0.14 | Protein-tyrosine phosphatase inhibitor | 0.14 0.09 DBMET01862 | DBMET01862 | |
| 0.042 | 0.589 | 0.429 | Antibacterial | 0.429 0.064 DBMET01858 | DBMET01858 | |
| 0.017 | 0.578 | 0.123 | Multidrug resistance-associated protein 1 inhibitor | 0.123 0.045 DBMET01859 0.116 0.054 DBMET01862 | DBMET01859 | |
| 0.019 | 0.588 | 0.159 | Platelet antagonist | 0.159 0.135 DBMET01858 | DBMET01858 | |
| 0.026 | 0.606 | 0.194 | Tumour necrosis factor alpha release inhibitor | 0.194 0.114 DBMET01858 | DBMET01858 | |
| 0.003 | 0.641 | 0.049 | Cholecystokinin B antagonist | 0.037 0.016 DBMET01859 0.049 0.01 DBMET01862 | DBMET01862 | |
| 0.011 | 0.729 | 0.136 | Thrombolytic | 0.136 0.093 DBMET01858 | DBMET01858 | |
| 0.027 | 0.749 | 0.497 | Cyclophilin D inhibitor | 0.497 0.051 DBMET01858 | DBMET01858 | |
| 0.008 | 0.764 | 0.373 | Cholecystokinin B agonist | 0.303 0.003 DBMET01859 0.373 0.003 DBMET01862 | DBMET01862 | |
| 0.011 | 0.771 | 0.103 | Cell adhesion inhibitor | 0.103 0.083 DBMET01858 | DBMET01858 | |
| 0.003 | 0.768 | 0.064 | Cholecystokinin antagonist | 0.047 0.026 DBMET01859 0.064 0.017 DBMET01862 | DBMET01862 | |
| 0.004 | 0.811 | 0.171 | Selectin antagonist | 0.171 0.015 DBMET01858 0.113 0.024 DBMET01861 | DBMET01858 | |
| 0.005 | 0.924 | 0.145 | Anticoagulant | 0.124 0.107 DBMET01859 0.145 0.085 DBMET01862 | DBMET01862 | |
| 0.002 | 0.925 | 0.076 | Cholecystokinin A antagonist | 0.041 0.024 DBMET01859 0.076 0.013 DBMET01862 | DBMET01862 | |
| 0.002 | 0.937 | 0.158 | Cholecystokinin agonist | 0.129 0.004 DBMET01859 0.158 0.003 DBMET01862 | DBMET01862 | |
| 0.002 | 0.947 | 0.137 | Cholecystokinin A agonist | 0.12 0.004 DBMET01859 0.137 0.003 DBMET01862 | DBMET01862 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |